Press Releases
June 27, 2005
Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product
April 21, 2005
Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology
March 1, 2005
Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma
February 7, 2005
Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)
January 4, 2005
H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding